Seagen Inc.
Masked Antibody Formulations

Last updated:

Abstract:

Formulations comprising masked antibodies are provided. In some embodiments, there is reduced aggregation of the masked antibodies in the formulations. In various embodiments, the formulations are pharmaceutical formulations suitable for use in therapeutic treatment.

Status:
Application
Type:

Utility

Filling date:

4 Jun 2020

Issue date:

28 Jul 2022